APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 217 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $460,284 | -61.2% | 12,100 | -7.2% | 0.00% | -50.0% |
| Q2 2023 | $1,187,580 | +57.8% | 13,036 | +14.2% | 0.00% | +100.0% |
| Q1 2023 | $752,736 | +27.5% | 11,412 | -0.1% | 0.00% | 0.0% |
| Q4 2022 | $590,425 | -26.0% | 11,418 | -2.2% | 0.00% | -50.0% |
| Q3 2022 | $798,000 | +32.1% | 11,680 | -12.5% | 0.00% | +100.0% |
| Q2 2022 | $604,000 | -19.0% | 13,347 | -9.1% | 0.00% | 0.0% |
| Q1 2022 | $746,000 | -39.5% | 14,676 | -43.7% | 0.00% | -50.0% |
| Q4 2021 | $1,233,000 | +131.8% | 26,074 | +61.6% | 0.00% | +100.0% |
| Q3 2021 | $532,000 | -37.3% | 16,136 | +20.2% | 0.00% | -50.0% |
| Q2 2021 | $848,000 | -22.8% | 13,422 | -47.5% | 0.00% | 0.0% |
| Q1 2021 | $1,098,000 | -17.6% | 25,588 | +9.9% | 0.00% | -33.3% |
| Q4 2020 | $1,332,000 | +348.5% | 23,286 | +136.3% | 0.00% | +200.0% |
| Q3 2020 | $297,000 | +10.8% | 9,856 | +20.2% | 0.00% | 0.0% |
| Q2 2020 | $268,000 | – | 8,199 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |